Delic’s First Acquisition in Bid to Become Psychedelic Clinic Leader

Ryan Allway

February 12th, 2021

Psychedelics, Top Story

The psychedelics industry is projected to reach nearly $7 billion by 2027, according to Data Bridge Market Research, representing a 16.3% compound annual growth rate. Most companies in the space are undergoing expensive preclinical and clinical trials to bring psilocybin and other psychedelics to market and treat unmet medical needs in mental health.

While psilocybin has been the primary focus, ketamine has been an approved anesthesia and acute pain management medication since the 1960s. The drug has been increasingly used off-label as a treatment for depression, and in 2019, the FDA approved an esketamine nasal spray to treat adults with major depressive disorder and acute suicidal ideation or behavior.

Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) in part, focusing on rolling up ketamine clinics across the country as a way to generate immediate cash flow in the psychedelics space with an existing FDA approved drug rather than going through expensive and time-consuming clinical trials. As additional psychedelic compounds are approved, these legal and established clinics could quickly expand their focus to serve client needs including PTSD, depression, anxiety and even bi-polar disorder.

The Beginning of a Roll-up Strategy

Delic has sought to expand from a central hub of psychedelics education, media and information to providing patients with psychedelic therapy through a planned roll-up and further acquisition strategy.

The company recently made its inaugural acquisition of Ketamine Infusion Centers LLC, which operates two ketamine infusion treatment clinics in Arizona and California. Since 2019, the company has generated $1.5 million in revenue with an experienced management team and six medical professionals that bring a wealth of industry knowledge and experience.

Click here to receive an investor presentation and corporate updates

Ketamine Infusion Centers LLC Offices

It’s not the Number of Clinics, This is an Experienced Team of Professionals That can Expand This Business Model Far and Beyond

“Our management team has been in the clinic and medical business for 15 years scaling and operating,” said KIC Co-Founder Sonny Diaz. “We jumped on the opportunity to join Delic as we feel the patient acquisition strategy—using Delic’s media platform to drive patients—is a potential game-changer. We think there is an opportunity to scale our SOPs and clinics over the next 18 months to be the national leader in the space.”

In addition to adding incremental revenue, the acquisition augments Delic’s management team with knowledge and experience in the ketamine clinic space. The company plans to use KIC’s best practices, including an insurance reimbursement program, to scale out its clinic footprint throughout the country over the coming quarters.

Unique Marketing Exposure

Delic has built an established education, media, and information presence through its Reality Sandwich education platform, Meet Delic wellness summit, and The Delic e-commerce brand.

Company management was responsible for helping High Times become the household cannabis brand that it is today. By leveraging that experience and in-depth industry relationships and its media business, the company aims to bring attention and awareness to its growing network of ketamine clinics as it pursues a roll-up acquisition and organic expansion strategy.

Reality Sandwich Education Portal

“From my years at High Times helping build the household cannabis brands of today, we know that in a nascent industry, whoever yells the loudest gets attention,” said Delic Founder and CEO Matt Stang. “Our media exposure and expertise is second to none in the industry and we feel like we can give a tremendous amount of attention to KIC and all future companies that join the Delic ecosystem.”

Looking Ahead

Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) made an inaugural acquisition that marks the beginning of a roll-up strategy in the ketamine clinic space. In addition to immediate cash flow, the company plans to leverage its media business to create awareness around the clinics and eventually become a nationwide leader in the space.

Click here to receive an investor presentation and corporate updates


The above article is sponsored content. and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation:

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Latest posts